These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 231702)

  • 21. Induction of angiotensin I-converting enzyme rat lung with Captopril (SQ 14225).
    Fyhrquist F; Forslund T; Tikkanen I; Grönhagen-Riska C
    Eur J Pharmacol; 1980 Oct; 67(4):473-5. PubMed ID: 6256177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Converting enzyme inhibition and modulation of plasma renin activity with captopril in anesthetized rats.
    Suzuki M; Satoh S
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):121-36. PubMed ID: 6275810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
    Cascieri MA; Bull HG; Mumford RA; Patchett AA; Thornberry NA; Liang T
    Mol Pharmacol; 1984 Mar; 25(2):287-93. PubMed ID: 6199659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiation of bradykinin by captopril during suppression of prostacyclin synthesis.
    Vandongen R; Tunney A; Barden A; Mahoney D
    Hypertension; 1982; 4(5):642-5. PubMed ID: 7049919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation by angiotensin converting enzyme inhibitor, SQ, 14225, of the analgesic effect of morphine in mice.
    Türker RK; Ilhan M; Ercan ZS
    Eur J Pharmacol; 1979 Sep; 58(1):99-100. PubMed ID: 227700
    [No Abstract]   [Full Text] [Related]  

  • 26. Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism.
    Zanzinger J; Zheng X; Bassenge E
    Cardiovasc Res; 1994 Feb; 28(2):209-14. PubMed ID: 8143302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
    Resende AC; Pimentel AM; de Moura RS
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vocalization response of puppies to intra-arterial administration of bradykinin and other algesic agents, and mode of actions of blocking agents.
    Taira N; Nakayama K; Hashimoto K
    Tohoku J Exp Med; 1968 Dec; 96(4):365-77. PubMed ID: 5718726
    [No Abstract]   [Full Text] [Related]  

  • 29. Angiotensin converting enzyme inhibitors, captopril and enalaprilat, augment bradykinin-induced prostacyclin synthesis in cultured rat vascular smooth muscle cells.
    Takeuchi K; Abe K; Sato M; Yasujima M; Omata K; Kasai Y; Kanazawa M; Fang SN; Yoshinaga K
    Adv Exp Med Biol; 1989; 247B():489-94. PubMed ID: 2558520
    [No Abstract]   [Full Text] [Related]  

  • 30. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
    DeForrest JM; Waldron TL; Harvey C; Scalese B; Rubin B; Powell JR; Petrillo EW; Cushman DW
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):730-6. PubMed ID: 2481187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.
    Waeber B; Brunner HR; Brunner DB; Curtet AL; Turini GA; Gavras H
    Hypertension; 1980; 2(2):236-42. PubMed ID: 6247269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of the pain-producing activity of otherwise biologically active synthetic fragments of bradykinin.
    Taira N; Hashimoto K
    Tohoku J Exp Med; 1973 Jun; 110(2):191-4. PubMed ID: 4729245
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN; Campbell BC; Reid JL
    J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vocalization response to close-arterial injection of bradykinin and other algesic agents in guinea pigs and its application to quantitative assessment of analgesic agents.
    Adachi KI; Ishii Y
    J Pharmacol Exp Ther; 1979 Apr; 209(1):117-24. PubMed ID: 430371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
    Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
    Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitor.
    Telford SE; Smith AI; Lew RA; Perich RB; Madden AC; Evans RG
    Br J Pharmacol; 1995 Mar; 114(6):1185-92. PubMed ID: 7620708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. More on captopril and measurement of angiotensin-converting enzyme.
    Dux S; Rosenfeld J; Yaron A; Carmel A
    N Engl J Med; 1981 Feb; 304(7):423-4. PubMed ID: 6256629
    [No Abstract]   [Full Text] [Related]  

  • 38. SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme.
    Rubin B; Laffan RJ; Kotler DG; O'Keefe EH; Demaio DA; Goldberg ME
    J Pharmacol Exp Ther; 1978 Feb; 204(2):271-80. PubMed ID: 202692
    [No Abstract]   [Full Text] [Related]  

  • 39. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
    van Esch JH; Tom B; Dive V; Batenburg WW; Georgiadis D; Yiotakis A; van Gool JM; de Bruijn RJ; de Vries R; Danser AH
    Hypertension; 2005 Jan; 45(1):120-5. PubMed ID: 15583077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats.
    Maia LG; Ramos MC; Fernandes L; de Carvalho MH; Campagnole-Santos MJ; Souza dos Santos RA
    J Cardiovasc Pharmacol; 2004 May; 43(5):685-91. PubMed ID: 15071356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.